Markets:

Overview

News

Currencies

International

Treasuries

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

1.260 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 25, 2023

Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 24, 2023

Via Benzinga

Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting

October 17, 2023

Via ACCESSWIRE

Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology

September 20, 2023

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Thursday ↗

October 05, 2023

On Thursday, 369 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance

September 19, 2023

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Monday ↗

September 11, 2023

Monday's session saw 175 companies set new 52-week lows.

Via Benzinga

Why Sonnet BioTherapeutics Stock (SONN) Is Getting Obliterated ↗

August 31, 2023

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 24% to $0.21 Thursay afternoon after the company announced a 1-for-22 reverse stock split.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 01, 2023

On Friday, 57 companies reached new 52-week lows.

Via Benzinga

Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split

August 31, 2023

Via ACCESSWIRE

7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole ↗

August 25, 2023

There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 18, 2023

Via Benzinga

Why Tower Semiconductor Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

August 16, 2023

Gainers

Via Benzinga

What's Going On With Sonnet BioTherapeutics Stock Today? ↗

August 16, 2023

Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) shares are trading higher after the company announced that the IND for SB221, the Phase 1b/2a trial of SON-1010 (IL12-FHAB) in combination with Roche...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 16, 2023

Via Benzinga

Sonnet BioTherapeutics Announces FDA Acceptance of the Company's IND for the SB221 Clinical Trial of SON-1010 Combined with Atezolizumab in the US

August 16, 2023

Via ACCESSWIRE

Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update

August 14, 2023

Via ACCESSWIRE

Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

August 01, 2023

Gainers American Superconductor Corporation (NASDAQ: AMSC) shares surged 112.1% to $21.38 in pre-market trading. AMSC is expected to report first-quarter results on Aug. 9, 2023.

Via Benzinga

Why Is SOFI Stock Up 19% Today? ↗

July 31, 2023

SoFi Technologies (SOFI) stock is on the rise Monday after the financial services company released results for the second quarter of 2023!

Via InvestorPlace

Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today? ↗

July 31, 2023

Sonnet BioTherapeutics (SONN) stock is taking a beating on Monday after the company announced details for a public stock offering.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 31, 2023

Via Benzinga

Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference

July 31, 2023

Via ACCESSWIRE

Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗

July 31, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

July 31, 2023

It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning!

Via InvestorPlace

Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations ↗

June 28, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 100 points on Wednesday. The Dow traded down 0.32% to 33,818.48 while the NASDAQ rose 0.23% to 13,586.93. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 28, 2023

Via Benzinga

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 28, 2023

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

Via Benzinga

Nasdaq Moves Higher; US Crude Stocks Drop More than Projected ↗

June 28, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday. The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today